TY - JOUR
T1 - 9-Amino-1,2,3,4-Tetrahydroacridine Is a Potent Inhibitor of Histamine N-Methyltransferase
AU - Nishibori, Masahiro
AU - Oishi, Ryozo
AU - Itoh, Yoshinori
AU - Saeki, Kiyomi
PY - 1991/1
Y1 - 1991/1
N2 - The effect of 9-amino-1,2,3,4-tetrahydroacridine (THA) on histamine N-methyltransferase (HMT), an enzyme catalyzing the methylation of histamine to form tele-methylhistamine in the brain, was studied in vitro using a partially purified enzyme preparation from bovine brain and in vivo in the mouse brain. THA inhibited the HMT activity in competitive and non-competitive mixed type manners with respect to histamine. The Ki and Ki values were 75 nM and 1.2 μM, respectively. The IC50 values for THA, 9-aminoacridine and physostigmine in the inhibition of HMT determined at fixed concentrations of histamine (20 μM) and S-adenosylmethionine (50 μM) were 0.2, 0.37 and 20 μM, respectively. Neostigmine exhibited only 15% inhibition even at a concentration of 100 μM. THA (2-10 mg/kg, s.c.) dose-dependently inhibited HMT in the mouse brain. The inhibition of HMT by THA (10 mg/kg) was marked at 30 and 60 min after treatment, but disappeared by 120 min after. THA (10 mg/kg) significantly increased the histamine level and decreased the tele-methylhistamine level in the mouse brain. These results indicate that THA is a potent inhibitor of HMT.
AB - The effect of 9-amino-1,2,3,4-tetrahydroacridine (THA) on histamine N-methyltransferase (HMT), an enzyme catalyzing the methylation of histamine to form tele-methylhistamine in the brain, was studied in vitro using a partially purified enzyme preparation from bovine brain and in vivo in the mouse brain. THA inhibited the HMT activity in competitive and non-competitive mixed type manners with respect to histamine. The Ki and Ki values were 75 nM and 1.2 μM, respectively. The IC50 values for THA, 9-aminoacridine and physostigmine in the inhibition of HMT determined at fixed concentrations of histamine (20 μM) and S-adenosylmethionine (50 μM) were 0.2, 0.37 and 20 μM, respectively. Neostigmine exhibited only 15% inhibition even at a concentration of 100 μM. THA (2-10 mg/kg, s.c.) dose-dependently inhibited HMT in the mouse brain. The inhibition of HMT by THA (10 mg/kg) was marked at 30 and 60 min after treatment, but disappeared by 120 min after. THA (10 mg/kg) significantly increased the histamine level and decreased the tele-methylhistamine level in the mouse brain. These results indicate that THA is a potent inhibitor of HMT.
UR - http://www.scopus.com/inward/record.url?scp=0025727739&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025727739&partnerID=8YFLogxK
U2 - 10.1254/jjp.55.539
DO - 10.1254/jjp.55.539
M3 - Article
C2 - 1886293
AN - SCOPUS:0025727739
SN - 0021-5198
VL - 55
SP - 539
EP - 546
JO - Japanese Journal of Pharmacology
JF - Japanese Journal of Pharmacology
IS - 4
ER -